Lotte Group's heir apparent joins Japan holding firm's board
The eldest son of Lotte Chairman Shin Dong-bin is its first third-generation family member to come to the fore
By Jun 27, 2024 (Gmt+09:00)
LG Chem to sell water filter business to Glenwood PE for $692 million


Kyobo Life poised to buy Japan’s SBI Group-owned savings bank


KT&G eyes overseas M&A after rejecting activist fund's offer


StockX in merger talks with Naver’s online reseller Kream


Mirae Asset to be named Korea Post’s core real estate fund operator



Shin Yoo-yeol, the heir apparent to Lotte Group, has been elected to the board of directors of its Japanese holding company, which serves as a link between the Korean and Japanese operations of the retail-to-chemical conglomerate.
His joining in the board of Lotte Holdings Co. is expected to accelerate the group’s management succession to the third generation of the founding family, solidifying his position as a senior leader of the group.
At a general shareholder meeting on Wednesday, Japan-based Lotte Holdings gave the nod to the junior Shin’s appointment as an inside director on its board. He is the eldest son of Lotte Group Chairman Shin Dong-Bin.
Lotte Holdings is controlled by Japanese property developer Kwang Yoon Sa, wholly owned by Lotte’s founding family.
It is at the top of the group’s ownership structure. The Japanese holding company controls Korea-based Hotel Lotte Co. that is then the largest shareholder of Korean holding firm Lotte Corp., the parent of Korean units focused on confectionary, chemical and retail businesses.
The junior Shin has been leading Lotte Corp.’s future growth office and Lotte Biologics Co.’s global strategy office as executive director since late last year.
His appointment to the executive positions at the two Korean units last December marked the first time that a third-generation family member of the conglomerate came to the fore.
The 38-year-old heir apparent has been groomed for top manager roles, mostly in Japan.
In February of this year, he was elected to the board of Lotte Biologics, a pharmaceutical company for contract development and manufacturing.
Early this month, he became a shareholder of Lotte Corp. with the purchase of a 0.01% stake in the Korean holding company.
Write to Sun A Lee at suna@hankyung.com
Yeonhee Kim edited this article.
-
BatteriesLotte Energy Materials sets sights beyond copper foil: CEO Kim
Jun 21, 2024 (Gmt+09:00)
4 Min read -
Banking & FinanceS.Korea’s Lotte Card injects $68 mn into Vietnamese unit
May 02, 2024 (Gmt+09:00)
1 Min read -
RetailKorea’s Lotte sells Lotte Glory Properties Shenyang amid US-China dispute
Apr 26, 2024 (Gmt+09:00)
3 Min read -
InsuranceKorea's Lotte Insurance put on market for around $1.5 bn
Apr 23, 2024 (Gmt+09:00)
1 Min read -
Corporate governanceLotte Group to give more authority to outside directors
Mar 20, 2024 (Gmt+09:00)
1 Min read -
Mergers & AcquisitionsLotte puts Lotte Chemical Titan in Malaysia on market
Mar 06, 2024 (Gmt+09:00)
4 Min read -
RetailLotte to sell 7-Eleven’s ATM unit in Korea for around $38 mn
Feb 07, 2024 (Gmt+09:00)
1 Min read -
Corporate restructuringLotte Group Chairman says to sell ailing units for new biz: report
Jan 30, 2024 (Gmt+09:00)
3 Min read -
Executive reshufflesLotte Group’s 3rd-generation son comes to the fore
Dec 06, 2023 (Gmt+09:00)
2 Min read -
Travel & LeisureLotte mulls Lotte World Tower spruce-up to rival Azabudai Hills Tower
Nov 24, 2023 (Gmt+09:00)
2 Min read